In the United States, the elderly are more likely to die of
a vaccine-preventable disease. Adult deaths from
influenza (≈36,000/y) (1,2), invasive pneumococcal disease
(≈9,000/y) (3), and hepatitis B (≈5,000/y) (4) exceed
vaccine-preventable deaths among children (≈50/y) by a
ratio of ≈1,000:1. For each of these diseases, case-fatality
rates rise with increasing age. This disparity can be
addressed through adult vaccination programs, which are
cost-effective and life-saving. Women constitute most of
the adult U.S. population >50 years of age (60% of those
75 years of age and 70% of those 85 years of age).
The immune system does not function as well with
advancing age (5). For example, T-cell functions diminish
with age, as evidenced by the increased prevalence of
anergy to mycobacterial and fungal skin-test antigens and
the increased frequency and severity of herpes zoster
infection with age. B-cell function diminishes, as seen with
the lessened humoral response (immunoglobulin [Ig] M,
IgG, and IgA) to certain vaccines (e.g., hepatitis B, influenza,
pneumococcal vaccine), and the protective efficacy of
these vaccines also decreases as recipients age (6,7).
Scientific explanations on how the brain deteriorates and ways to maintain proper functioning.
Warning signs and preventative measures to help identify and reduce the risk of breast cancer.